Literature DB >> 18477966

The role of loperamide in gastrointestinal disorders.

Stephen B Hanauer1.   

Abstract

Loperamide is an effective therapy for a variety of diarrheal syndromes, including acute, nonspecific (infectious) diarrhea; traveler's diarrhea; and chemotherapy-related and protease inhibitor?associated diarrhea. Loperamide is effective for the "gut-directed" symptom of diarrhea in patients with painless diarrhea or diarrhea-predominant irritable bowel syndrome. Loperamide and diphenoxylate are commonly used to treat diarrhea in numerous settings of inflammatory bowel disease. Loperamide has also been observed to increase anal sphincter tone, which may lead to improvement of fecal continence in patients with and without diarrhea. Loperamide is generally well tolerated at recommended nonprescription doses, with the most common side effects related to the impact on bowel motility (abdominal pain, distention, bloating, nausea, vomiting, and constipation).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477966

Source DB:  PubMed          Journal:  Rev Gastroenterol Disord        ISSN: 1533-001X


  19 in total

1.  Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2.

Authors:  Yun-Qing Song; Rong-Jing He; Dan Pu; Xiao-Qing Guan; Jin-Hui Shi; Yao-Guang Li; Jie Hou; Shou-Ning Jia; Wei-Wei Qin; Sheng-Quan Fang; Guang-Bo Ge
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 2.  A review on functional results of sphincter-saving surgery for rectal cancer: the anterior resection syndrome.

Authors:  Filippo Pucciani
Journal:  Updates Surg       Date:  2013-06-11

3.  Prostatic relaxation induced by loperamide is mediated through activation of opioid μ-2 receptors in vitro.

Authors:  Chih-Cheng Lu; Hsien-Hui Chung; Juei-Tang Cheng
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

4.  Analgesic properties of loperamide differ following systemic and local administration to rats after spinal nerve injury.

Authors:  C Chung; A F Carteret; A D McKelvy; M Ringkamp; F Yang; T V Hartke; X Dong; S N Raja; Y Guan
Journal:  Eur J Pain       Date:  2012-04-16       Impact factor: 3.931

5.  Opiate-induced constipation related to activation of small intestine opioid μ2-receptors.

Authors:  Wency Chen; Hsien-Hui Chung; Juei-Tang Cheng
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 6.  Management of patients with faecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Jonas Worsoe; Lilli Lundby; Peter Christensen; Klaus Krogh
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

7.  Laboratory testing of clinically approved drugs against Balamuthia mandrillaris.

Authors:  Huma Kalsoom; Abdul Mannan Baig; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  World J Microbiol Biotechnol       Date:  2014-05-30       Impact factor: 3.312

8.  Peripherally Acting μ-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats.

Authors:  Vinod Tiwari; Michael Anderson; Fei Yang; Vineeta Tiwari; Qin Zheng; Shao-Qiu He; Tong Zhang; Bin Shu; Xueming Chen; Shaness A Grenald; Kimberly E Stephens; Zhiyong Chen; Xinzhong Dong; Srinivasa N Raja; Yun Guan
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

9.  In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.

Authors:  Abdul Mannan Baig; Junaid Iqbal; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

10.  Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.

Authors:  Arlet Loza-Huerta; Edgar Milo; Arturo Picones; Arturo Hernández-Cruz; Enoch Luis
Journal:  Pharmacol Rep       Date:  2021-07-02       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.